| Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA M Dileepan, D Di, Q Huang, S Ahmed, D Heinrich, H Ly, Y Liang Virulence 12 (1), 1597-1609, 2021 | 70 | 2021 |
| Recombinant SARS-CoV-2 nucleocapsid protein: Expression, purification, and its biochemical characterization and utility in serological assay development to assess immunological … D Di, M Dileepan, S Ahmed, Y Liang, H Ly Pathogens 10 (8), 1039, 2021 | 13 | 2021 |
| Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens S Ahmed, D Parthasarathy, R Newhall, T Picard, M Aback, S Ratnapriya, ... NPJ vaccines 8 (1), 181, 2023 | 5 | 2023 |
| Alternative substitutions of N332 in HIV-1AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies … J Jeffy, D Parthasarathy, S Ahmed, H Cervera-Benet, U Xiong, M Harris, ... Mbio 15 (4), e02686-23, 2024 | 4 | 2024 |
| SARS-CoV-2 in companion animals: Do levels of SARS-CoV-2 seroconversion in pets correlate with those of pet’s owners and with protection against subsequent SARS-CoV-2 infection? H Murphy, S Sanchez, S Ahmed, MM Rahman, D Di, M Dileepan, ... Virulence 13 (1), 1216-1220, 2022 | 4 | 2022 |
| Insights from HIV-1 vaccine and passive immunization efficacy trials S Ahmed, Herschhorn Safety, 2024 | 1 | 2024 |
| mRNA-based HIV-1 vaccines S Ahmed, A Herschhorn Clinical Microbiology Reviews, e00041-24, 2024 | | 2024 |
Yuying LiangUniversity of Minnesota在 umn.edu 的电子邮件经过验证
